Our Fall 2019 issue, Volume 9, Issue 1, includes an exciting and rich collection of works that spans an unusually broad, yet timely and relevant, variety of topics in the areas of IP and entertainment law and policy.
This Article addresses the black market for college athlete services that results from the NCAA’s restrictions on athlete compensation based on the purported need to preserve amateurism. Specifically, this Article focuses on the NCAA’s name, image, and likeness (NIL) restrictions that prevent college athletes from making use of their own reputations for commercial purpose.
It’s the policy of an increasing number of news outlets to retain ownership of the professional
social media accounts of their reporters. In the first case of its kind in the United States, one media company took a former employee to court over the question of ownership.
This Article explores the law and economics of “literary fan art”—unauthorized derivative works by third parties that are based on someone else’s literary work product. What is the legal status of such fan art?
Since 1996, the annual spending on drugs per capita in the U.S. has been the highest among all the developed countries. In 2017, the number reached $1220 per person in the U.S., making the U.S. pharmaceutical industry a $400 billion market. One of the fastest growing segments of the pharmaceutical industry is biologic drugs, accounting for almost 40% of the U.S. prescription drug spending in 2015.
Blockchain, cryptocurrency, smart contracts—these obscure terms began flooding the news a few years ago and for good reason. These are technologies with the potential to fundamentally change the way in which society performs its business transactions.